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Endocytosis and local protein synthesis (LPS) act coordinately to mediate the
chemotropic responses of axons, but the link between these two processes is
poorly understood. The endosomal sorting complex required for transport
(ESCRT) is a key regulator of cargo sorting in the endocytic pathway, and
here we have investigated the role of ESCRT-II, a critical ESCRT component,
in Xenopus retinal ganglion cell (RGC) axons. We show that ESCRT-II is pre-
sent in RGC axonal growth cones (GCs) where it co-localizes with endocytic
vesicle GTPases and, unexpectedly, with the Netrin-1 receptor, deleted in col-
orectal cancer (DCC). ESCRT-II knockdown (KD) decreases endocytosis and,
strikingly, reduces DCC in GCs and leads to axon growth and guidance
defects. ESCRT-II-depleted axons fail to turn in response to aNetrin-1 gradient
in vitro and many axons fail to exit the eye in vivo. These defects, similar to
Netrin-1/DCC loss-of-function phenotypes, can be rescued in whole (in
vitro) or in part (in vivo) by expressing DCC. In addition, ESCRT-II KD impairs
LPS in GCs and live imaging reveals that ESCRT-II transports mRNAs in
axons. Collectively, our results show that the ESCRT-II-mediated endocytic
pathway regulates both DCC and LPS in the axonal compartment and suggest
that ESCRT-II aids gradient sensing in GCs by coupling endocytosis to LPS.
1. Introduction
During development, neurons send out axons that navigate long distances to their
synaptic targets. Growth cones (GCs), located at the tips of growing axons,
respond directionally to cues in their environment and are essential for this
navigation. Extrinsic cues bind and activate receptors in GCs and stimulate endo-
cytosis [1–5]. The guidance receptors deleted in colorectal cancer (DCC) and
neuropilin, for example, are rapidly endocytosed upon binding Netrin-1 and
Sema3A, respectively [3–6]. Endocytosis is required for the collapse response of
GCs to repulsive cues [4,7] and polarized endocytosis underlies the steering
responses of GCs to a cue gradient [8,9]. Gradient-elicited GC steering similarly
involves a polarized pattern of de novo protein synthesis (PS) [10,11] and GC
adaptation, a key feature of gradient sensing, relies on the coupled action of endo-
cytosis and local protein synthesis (LPS) [5] suggesting that these two processes
are closely linked. Indeed, mRNA transport is directly linked to endosomes in
fungal hyphae where it assists with precise subcellular targeting of locally
synthesized proteins [12].
Activated receptorcomplexes [13,14] enter the endocytic pathwayandare sorted
into specific vesicles fromwhere they can continue to signal [15–18]. Correct sorting
and transport of endocytosed receptors are necessary for their function in GCmoti-
lity and guidance [19]. Different classes of vesicles, named early, late and recycling
endosomes, carry cargoes destined for either recycling or degradation. The
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endosomal sorting complex required for transport (ESCRT)
machinery controls the passage of endocytosed cargo between
different types of endosomes. It consists mostly of vacuolar
protein sorting (Vps) proteins and multiple associated factors
organized into complexes named ESCRT-0, ESCRT-I, ESCRT-II
and ESCRT-III [20]. The ESCRT systemwas originally identified
for its involvement in endosomal sorting of ubiquitylated
proteins andmultivesicular endosomebiogenesis [21].However,
ESCRT components are nowknown to regulatemanyadditional
cellular functions, including receptor signalling, polarity,
migration, cytokinesis, viral budding, autophagy, exosome
secretion, miRNA activity and mRNA transport [22–26].
While the ESCRT system commonly works together as a
coordinate set of proteins [27], individual ESCRT components
can function independently. Of particular interest, ESCRT-II
can act as an RNA binding protein [28], and endosomes have
been implicated in mRNA transport and local translation
[29–31]. Cue-induced LPS in GCs is known to play a role in
axon navigation [32], and guidance cue receptors involved in
triggering axonal PS such as tropomyosin receptor kinase B
(TrkB), Neuropilin-1 or DCC undergo ligand-induced endocy-
tosis [5,6], linking them to the endosomal pathway. Regulation
of endosomes by ESCRT plays a role in axonal branching
[33,34] and pruning [35] but it is not yet known whether
ESCRT proteins have a role in GC guidance. Therefore, we
have investigated if ESCRT-II could play such a role. Our
results show that ESCRT-II co-localizes with DCC and endo-
somes in GCs and provide evidence that ESCRT-II is needed
for cue-induced LPS and axon guidance.
2. Material and methods
2.1. Embryos
Xenopus laevis embryos of either sex were obtained by in vitro
fertilization, raised in 0.1 modified Barth’s saline (MBS) at
14–188C and staged according to the tables of Nieuwkoop
and Faber (1994).
2.2. Constructs, morpholinos and antibodies
2.2.1. Constructs
Xenopus laevis ESCRT-II subunits EGFP-Vps22, Vps25 and
Vps36, mouse DCC and gap-GFP were cloned into pCS2
vector. GeneMachine Kit (Ambion) was used to make mRNA.
2.2.2. Morpholinos
Antisense morpholino oligonucleotides (MOs) either non-
modified or conjugated to carboxyfluorescein were purchased
from GeneTools. Xenopus laevis Vps25 splice blocking MOs:
50-GCTGTGCCCACCACACCGCTCACGT-30 and 50-CAACT
TTCCTGGAACACAGTATGTT-30. Control MO: 50-CCTCTT
ACCTCAGTTACAATTTATA 30.
2.2.3. Antibodies
Rabbit anti-Xenopus laevis ESCRT-II polyclonal antibody was
made in the Blower laboratory; other antibodies were obtained
as follows: mouse anti-acetylated a-tubulin (Sigma cat. no.
T6793), mouse anti-a-tubulin (Sigma cat. no. T6074), mouse
anti-Rab4 (BD Biosciences cat. no. 610888), mouse anti-Rab5
(BD Biosciences cat. no. 610281), mouse anti-Rab7 (Sigma cat.
no. R8779), mouse anti-Rab11 (BD Biosciences cat. no. 610656),
rabbit anti-b-tubulin (Abcam cat. no. ab6046), mouse anti-DCC
intracellular domain (BD Biosciences cat. no. 554223), goat anti-
DCC extracellular domain (R&D Systems cat. no. AF844),
rabbit anti-RPL5 (Proteintech Europe cat. no. 15430-1-AP).
2.4. Cell cultures
Eye primordia were dissected from stage 24 X. laevis embryos
and plated on 50 mm glass-bottom dishes (MatTek) coated
with 10 mg ml21 poly-L-lysine and 10 mg ml21 laminin (both
fromSigma). Explantswere cultured at 208C in 60%Leibowitz’s
L15 medium (Gibco) containing 5% penicillin/streptomycin/
fungizone (Sigma cat. no. P4458) and 50 mg ml21 gentamycin
(GE Healthcare) for 16–18 h.
2.5. Immunostaining
Axons growing from Xenopus eyes cultured in glass-bottom
dishes were fixed with 2% paraformaldehyde (Pfa)/7.5%
sucrose in 1 phosphate-buffered saline (PBS) for 20 min at
room temperature (RT), washed with PBS, permeabilized with
0.1% Triton X-100 in PBS for 5 min at RT, blocked with 5%
goat serum in PBS for 30 min at RT, then incubated with the
primary antibody for 1 h at RT followed by a fluorochrome-
conjugated secondary for 30 min at RT. Where appropriate,
Phalloidin-Alexa Fluor 488 (an F-actin stain; 1 : 100, Invitro-
gen/Molecular Probes) was added together with the second
antibody. GCs were mounted in Fluorosave (Calbiochem), cov-
erslipped and imaged on a Nikon Eclipse TE2000-U inverted
microscope fitted with an Hamamatsu C4742-80-12AG
camera. Co-localization images were taken on a spinning disk
microscope (UltraVIEW Vox system (PerkinElmer) mounted
on an Olympus IX81 inverted microscope) equipped with an
EM-CCD camera (C9100-50, Hamamatsu).
2.5.1. Surface/total DCC staining
Axons cultured in glass-bottomdisheswere fixedwith 2%Pfa/
7.5% sucrose in 1 PBS for 5 min on ice. After four quick
washes with ice-cold PBS, the axons were incubated with
goat anti-DCC extracellular domain antibody (R&D Systems
cat. no. AF844) at 1 : 20 in PBS/0.1% BSA for 30 min on ice
and washed 4 2 min with ice-cold PBS. Axons were then
fixed again with 2% Pfa/7.5% sucrose in 1 PBS for 20 min
at RT, washed with PBS, permeabilized with 0.1% Triton
X-100 in PBS for 5 min at RT and incubated with mouse anti-
DCC intracellular domain antibody (BD Biosciences cat. no.
554223) for for 1 h at RT, followed by a mix of donkey second-
ary antibodies (anti-goat Alexa Fluor 568 and anti-mouse
Alexa Fluor 647) for 30 min at RT. GCs were mounted
in Fluorosave (Calbiochem), coverslipped and imaged on
a Nikon Eclipse TE2000-U inverted microscope fitted with a
Hamamatsu C4742-80-12AG camera.
2.6. Western blot
Stage 37–38Xenopus embryoswere anaesthetized in 0.4 mg ml21
tricaine methanesulfonate (MS222) in 1 MBS and their eyes
were dissected, homogenized and lysed in RIPA buffer
(Sigma cat. no. R0278) containing cOmplete Mini EDTA-free
protease inhibitor cocktail (Roche cat. no. 11 836 170 001)
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and spun on a bench-top centrifuge at 48C to clear the lysates.
The protein supernatants were resolved on 12% or 4–20%
gradient Mini-Protean gels (Bio-Rad) and transferred to nitro-
cellulosemembrane (Bio-Rad). Themembranewas blocked for
30 min in 5% skimmed milk in Tris-buffered saline–Tween 20
(TBS-T: 150 mM NaCl, 50 mM Tris–HCl, pH 8.0, 0.05%
Tween) at RT and incubated with primary antibodies: rabbit
anti-ESCRT-II 1 : 1000 or mouse anti-DCC (BD Transduction
labs) 1 : 1000 or mouse anti-a-tubulin (Sigma cat. no. T6074)
1 : 5000 in 5% milk/TBS-T for 2 h at RT, followed by either
horseradish peroxidase-conjugated anti-rabbit or anti-mouse
secondary antibody (both Abcam, 1 : 5000) for 1 h at RT.
Bands were detected on GE Healthcare Hyperfilm ECL films
using an ECL Plus detection kit (Amersham) and X-ray
developer.
2.7. Electroporation
Eye-targeted electroporation was performed on stage 26–28
embryos as previously described [36]. Embryos anaesthetized
with 0.4 mg ml21 MS222 in 1 MBS were placed yolk-up in
the longitudinal channel of a cross-shaped Sylgard chamber, so
that the eyes faced the homemade platinum electrodes.
A solution of 1 mg ml21 DNA or 1 mM fluorescein-tagged MO
was microinjected into the lumen of the eye vesicle and a 1 Hz
series of eight pulses (18 V and 50 ms long) was delivered by a
square wave pulse generator (TSS20 OVODYNE Electroporator,
Intracel). Embryos were returned to 0.1 MBS and grown at
188C until reaching stage 41. Embryos were either imaged live
(see §2.8) or fixed in 4% Pfa in PBS overnight at 48C, embedded
in OCT compound and cryosectioned to 12 mm thick sections
mounted on microscope slides. Sections were stained with
DAPI and imaged on a Nikon Eclipse 80i upright microscope.
2.8. In vivo ventral brain preparation
Stage 41 embryos were lightly anaesthetized in 1 MBS with
0.4 mg ml21 of MS222. The ventral surface of the brain was
exposed by carefully slicing through from the position directly
dorsal to the cement gland to the posterior hindbrain.
The exposed brains were then bathed in 1 MBS with
0.1 mg ml21 of MS222 and mounted in ventral view in order
tovisualize thewhole optic path, and imagedonaNikonEclipse
80i upright microscope.
2.9. Microinjections
The procedure was performed as described previously [37].
Briefly, jelly coats of the in vitro fertilized embryos were
removed with 2% cysteine (Sigma) solution in 1 MBS.
MOs (12 ng per blastomere) and mRNAs were diluted in
RNase-free water and microinjected into both dorsal animal
blastomeres (a volume of 5 nl blastomere21) at the four-cell
stage in a solution of 4% Ficoll (Sigma) in 1 MBS.
2.10. In vitro axon outgrowth assay
Time-lapse recordings were performed on explanted whole
Xenopus eye primordia from stage 24 cultured in 50 mm glass-
bottom dishes (MatTek) for 16–18 h. Phase contrast images
were taken every 5 min for a total of 2 h (see figure 3 for details)
using 20 on a Nikon Eclipse TE2000-U inverted microscope
fitted with a motorized XY stage (Prior Scientific, Cambridge,
UK) and an automatic shutter. Axons from four to five explants
per dish were imaged at the same time. The same axons were
traced before and after adding Netrin-1. The average speed of
growth was calculated in Microsoft EXCEL from the total dis-
tance covered by the GC in periods before and after Netrin-1
using IMAGEJ (FIJI) plugin Manual Tracking.
2.11. Growth cone turning assay
Retinal explants from stage 24 Xenopus eye primordia were pre-
pared as described and plated on poly-L-lysine-coated 50 mm
glass-bottom dishes (MatTek). Retinal explants were cultured
for 18 h at 208C before turning assays. Netrin-1 gradients were
produced by pulsatile ejection of 10 mg ml21 mouse recombi-
nant Netrin-1 (R&D Systems cat. no. 1009-N1) solution in
culture media from a glass micropipette using a pressure appli-
cation system (Picospritzer, General Valve). The pipette tip was
placed 100 mm from the GC at a 458 angle from the direction of
growth, resulting in an approximately 103-fold dilution of
Netrin-1 at the GC. Phase-contrast images were acquired
every 5 min for 1 h. Turning angle was defined as the angle
between the original direction of growth and the direction
after 1 h. Only GCs that extended 5 mm over 1 h were included
in the analysis. Unlike the other in vitro experiments in this
paper, for turning assays laminin coating was not used as it is
known to interfere with attractive Netrin-1 signalling [38].
2.12. Proximity ligation assay
This was performed according to the manufacturer’s instruc-
tions (Olink Bioscience) with modifications [39]. Briefly, eye
explant cultures grown in glass-bottom dishes were fixed, per-
meabilized and blocked exactly as for immunostaining.
The pair of primary antibodies, either mouse anti-DCC
intracellular domain (1 : 100, BD Biosciences) and rabbit anti-
ESCRT-II (1 : 200) or the same anti-DCC and rabbit anti-RPL5
(1 : 100, Proteintech Europe cat. no. 15430-1-AP), were applied
and incubated overnight at 48C. The dishes were washed 4
5 min in PBS/0.002% Triton X-100 followed by application of
anti-rabbit (þ) and anti-mouse (2) probes for 1 h at 378C,
ligase for 30 min at 378C and the polymerase mix with green
fluorescence for 100 min at 378C. The samples were mounted
in Duolink mounting media and imaged on the same day.
2.13. FM4-64 dye incorporation
Experiments were performed on RGC axons growing from
whole Xenopus eye primordia from stage 24 embryos cultured
in 50 mm glass-bottom dishes (MatTek) for 16–18 h. A stock
of 2 mM aqueous solution of fixable FM4-64FX (Molecular
Probes/Life Technologies) was vortexed, filtered through a
0.22 mm syringe filter and diluted 1 : 200 in 60% L15 culture
media. The working solution was applied to cells for 90 s at
RT. Dishes were subsequently put on ice and washed 3
with ice-cold culture media before being fixed in 2% Pfa/
7.5% sucrose in PBS for 20 min at RT. Fluorescent images
were acquired on a Nikon TE2000-Umicroscope at 60magni-
fication. Total FM dye fluorescent intensity was measured and
background subtracted in IMAGEJ (FIJI).
2.14. L-Azidohomoalanine incorporation assay
Stage 24 Xenopus eye explant cultures were incubated in
methionine-free 60% L15 media for 6 h prior to the exper-
iments. L-Azidohomoalanine (AHA; Life Technologies cat.
rsob.royalsocietypublishing.org
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no. C10102) 200 mM concentration was added for 1 h, then
washed with embryo media followed by PBS. Explants
were fixed with 2% Pfa/7.5% sucrose in PBS for 20 min at
RT, washed 3 with 3% BSA/PBS and permeabilized with
0.1% Triton X-100 in PBS, and the Click reaction was per-
formed with Click-iT Alexa Fluor 488 detection reagent,
according to manufacturer’s instructions (Life Technologies).
Culture dishes were mounted in Fluorosave and imaged.
2.15. Puromycin labelling assay
Xenopus eye explants (either non-stimulated (i.e. time 0 min)
or Netrin-1 (300 ng ml21) stimulated for 25 or 40 min; see
Results and figure 7) were incubated with 10 mg ml21 puro-
mycin (Sigma cat. no. p8833) in culture media for 10 min
(the final 10 min of Netrin-1 stimulation) at RT, washed 3
with ice-cold culture media, fixed with 2% Pfa/7.5% sucrose
in PBS for 20 min at RT, washed in PBS/1 mg ml21 saponin,
permeabilized in 10 mg ml21 saponin/PBS for 5 min at RT,
blocked in 5% goat serum/1 mg ml21 saponin in PBS for
1 h and incubated with anti-puromycin antibody directly
conjugated to Alexa Fluor 488 (Millipore/Molecular Probes
cat. no. MABE343-AF488; diluted 1 : 250) overnight at 48C
in blocking solution, washed 5 5 min in PBS/1 mg ml21
saponin, mounted in Fluorosave (Calbiochem) and imaged.
2.16. Live imaging of ESCRT-II and mRNA
Xenopus embryos were co-injected with mRNAs encod-
ing Vps25 (400 pg blastomere21), EGFP-Vps22 and Vps36
(200 pg blastomere21 each) and Cy3-labelled b-actin
mRNA (500 pg blastomere21) at the four-cell stage and eye
cultures in glass-bottom dishes were prepared as described.
Live movies of EGFP-ESCRT-II and Cy3-b-actin mRNA in
axons were recorded using a spinning disc confocal micro-
scope (UltraVIEW Vox system (PerkinElmer mounted on
Olympus IX81 inverted microscope) equipped with an
EM-CCD camera (C9100-50, Hamamatsu), controlled by
VOLOCITY software set to maximum sample protection;
single plane frames were acquired every 2 s (alternating
between 488 and 543 laser lines) for up to 5 min. The
movies were post-processed using both VOLOCITY and
IMAGEJ software to suppress noise.
2.17. Statistical analysis
Statistical analyses were performed using GRAPHPAD PRISM
v. 5 software. For each experimental group, D’Agostino and
Pearson omnibus normality test was run, followed by either
Anova þ Bonferroni/Student’s t-test/uncorrected Fisher’s
LSD (for normally distributed samples) or Kruskal–Wallis þ
Dunnis/Mann–Whitney test.
3. Results
3.1. ESCRT-II localizes to endosomal compartments in
axonal growth cones
To determine the role of ESCRT-II in axon guidance, we first
examined its localization in the GC. Immunostaining of cul-
tured RGCs with a specific anti-Xenopus ESCRT-II antibody
revealed positive punctate staining in the axons, as well as
in the central and the peripheral domains of GCs
(figure 1a–d). ESCRT-II-positive puncta were especially evi-
dent along F-actin-rich (phalloidin-positive) filopodia [40],
where they often resembled a ‘string of beads’
(figure 1a,b,d). Stable microtubules, detected by anti-
acetylated tubulin, typically localize to the GC central
domain (figure 1c).
The localization and function of ESCRT components over-
lap with those of the Rab family of small GTPases [41,42].
Rab5 is associated with early endosomes, Rab4 labels ‘short
loop’ recycling endosomes, Rab11 associates with ‘long
loop’ recycling endosomes and Rab7 marks late endosomes
which send the cargo for degradation in lysosomes [43]
(figure 1e). We therefore assessed the levels of co-localization
of these Rabs with ESCRT-II. The markers of early/recycling
endosomes (Rab5 and Rab4) as well as late and ‘long loop’
recycling endosomes (Rab7 and Rab11) were found to co-
localize with ESCRT-II (figure 1f– j). This suggests that
ESCRT-II is associated with both the early and late part of
the endosomal pathway, including recycling endosomes, in
GCs.
3.2. ESCRT-II depletion reduces endocytosis
Given the importance of membrane dynamics in the GC, we
next investigated whether ESCRT-II is required for GC endo-
cytosis using a loss-of-function approach. Because ESCRT
function is essential for embryonic development [44], we
chose a KD approach. We targeted the Vps25 subunit with
a specific splice-blocking antisense morpholino (MO) and
achieved a 42+4.3% knockdown as measured by western
blot analysis of stage 33/34 eye extracts (figure 2a).
To test whether ESCRT-II regulates endocytosis in RGC
GCs, we exposed control- and ESCRT-II KD GCs to the styryl
dye FM4-64FX [2,45] for 90 s, washed out the dye, and fixed
the samples. Control GCs exhibited a robust FM4-64 signal,
whereas in ESCRT-II-depleted GCs the signal was significantly
reduced (figure 2b–d). This decrease of FM4-64 signal indicates
that ESCRT-II knockdown impairs endocytosis. Alternatively,
given the highly dynamic nature of GC endosomes and recy-
cling turnover [45], it is possible that this decrease reflects an
increase in the recycling rate of endocytosed vesicles and their
reinsertion back into plasma membrane.
3.3. Axons grow abnormally when ESCRT-II is depleted
The speed of axon extension is, in part, controlled by a balanced
rate of insertion and removal of lipidmembrane through exocy-
tosis and endocytosis, respectively [46–50]. When membrane
insertion exceeds removal, axons extend and, therefore, a
reduction in endocytosis would be predicted to increase the
rate of axon extension. In line with this, measurements of
basal axon extension rates in vitro showed that ESCRT-II-
depleted GCs advance faster than controls (average 61.3+
1.5 mm h21 versus 54.6+1.22 mm h21; figure 2e–i).
We next asked whether ESCRT-II is required for normal
axon growth in vivo. We used electroporation to target the
MOs (together with a reporter gap-GFP plasmid) directly
into retinal cells at stage 26 when RGCs are newly born.
We found that GFP-labelled axons exiting the eye, crossing
the chiasm and entering the optic tract were markedly spar-
ser in ESCRT-II MO-electroporated brains (less than five
axons) compared with the control MO-electroporated ones
rsob.royalsocietypublishing.org
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Figure 1. ESCRT-II co-localizes with early endosomal vesicles in RGC growth cones. (a–d) ESCRT-II immunoreactivity in GCs (a) co-labelled with F-actin (b; strongly
labelling GC periphery including filopodia) and acetylated a-tubulin (c; predominantly staining axon shaft and GC central domain). Panel (d ) shows a compound
image of (a–c). Note ESCRT-II-positive granules in GC filopodia (insets a–d). (e) Cartoon depicts the involvement of individual Rabs with distinct elements of the
endocytic pathway. ( f– i) Co-localization of ESCRT-II with endosomal markers Rab5 ( f ), Rab11 (g), Rab4 (h) and Rab7 (i) in RGC GCs. Arrows point to spots where
the signals visibly co-localize. GC outline indicated with yellow line. ( j ) Table shows average Manders’ co-localization coefficients of Rabs and ESCRT-II in whole GC
and filopodia. Scale bars, 10 mm.
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(more than 10 axons; figure 3a,b). Even though the eye size
was unchanged in the ESCRT-II MO electroporated
embryos, this difference could potentially reflect fewer
ESCRT-II-MO-positive cells in the retina owing to increased
cell death. To address this possibility, we sectioned the elec-
troporated eyes and counted the number of axons and the
number of electroporated (MO- and GFP-positive) cells in
the DAPI-stained RGC layer. On average, there were 9.7+
0.88 labelled axons exiting the control MO-electroporated
eye, whereas the mean number of axons exiting the
ESCRT-II MO-electroporated eyes was significantly reduced
to 3.7+ 0.47. The average number of MO-positive cell
bodies in the RGC layer, however, was similar in both con-
ditions (23.8+ 5.64 control MO and 23.1+ 2.75 ESCRT-II
MO; figure 3c–e), suggesting that the decrease of RGC
axons exiting the eye was not a secondary effect owing to
RGC cell death. Collectively, the results indicate that
ESCRT-II-depleted RGCs show axon growth defects in vivo
as well as in vitro.
3.4. ESCRT-II regulates the response of retinal ganglion
cell axons to Netrin-1
One of the key ligands known to guide axons out of the eye is
Netrin-1, which is expressed exclusively at the optic nerve
head [51–53]. We therefore asked if Netrin-1 responsiveness
was affected in ESCRT-II-depleted neurons. Addition of
Netrin-1 globally to cultured retinal axons stimulates an
increase in the rate of axon extension by more than 40%
[53]. We tested if ESCRT-II morphants retained their sensi-
tivity to Netrin-1. Addition of 300 ng ml21 Netrin-1 to the
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culture medium increased the speed of axon growth of con-
trol MO-injected axons by 21.9+2.5% but it slightly
decreased the speed of growth of ESCRT-II-depleted axons.
This effect was rescued by ESCRT-II expression, which
restored axon speed to control Netrin-1 stimulated levels
(figure 4a,b). This indicates that ESCRT-II is involved in
regulating Netrin-1 sensitivity.
3.5. ESCRT-II co-localizes and regulates DCC levels
Previous findings showing that ligand-induced endocytosis
of Netrin-1’s receptor, DCC, is necessary to mediate Netrin-1
signalling in GCs [5] prompted us to investigate a potential
link between ESCRT-II and DCC. Co-immunolabelling for
DCC and ESCRT-II showed a high degree of overlap between
the two signals in the GC central domain and filopodia
(figure 5a–d) that was not altered by 10 min Netrin-1 (data
not shown). To further validateDCC–ESCRT-II co-localization,
we used the proximity ligation assay (PLA) [39,54], which
detects when two proteins are 40 nm or less apart and,
therefore, potentially interacting. GCs showed a strong
DCC–ESCRT-II PLA signal (figure 5e,g). Interestingly, when
compared with the PLA signal between DCC and one of its
known direct-binding partners, RPL5 [55], the PLA signal
of ESCRT-II–DCC was significantly more abundant
(figure 5e–g). This suggests the possibility that ESCRT-II and
DCC interact directly in the GC.
Remarkably, we found that when ESCRT-II was reduced
by 50.5+4.3% with ESCRT-II MO (figure 6a,c,g), DCC was
correspondingly decreased (51.5+6.5%; figure 6b,d,h). This
decrease was rescued by overexpression of ESCRT-II restoring
the levels of DCC to 106.6+13.3% of control (figure 6e–h).
Western blot analysis on whole eyes confirmed these ESCRT-
II-associated changes in DCC levels (figure 6i). These results
indicate that ESCRT-II regulates DCC levels.
The impaired endocytosis (or faster recycling) in ESCRT-
II morphant axons (figure 2b–d) indicates that DCC could be
specifically inserted or removed from the GC plasma mem-
brane. To test this possibility, we assessed the surface
fraction of the DCC receptor using an antibody against the
extracellular domain in non-permeabilized conditions. We
found that in ESCRT-II-depleted GCs, the total DCC levels
were reduced by 39.4+ 8.3% (figure 7a,c,e), whereas the cor-
responding surface fraction was reduced by 38.1+ 7.6%
(figure 7b,d,f ), compared with control GCs. The surface-to-
total DCC ratios were almost identical in control and
ESCRT-II-deficient GCs (figure 7g), indicating that the loss
of total DCC is accompanied by a proportional loss of the
control MO ESCRT-II MO
chiasm
tectum
tectum
electroporated
eye
chiasm
ONH
lens
ONH
RGC layer
ONH
lens
ONH
RGC layer RGC layer
RGC layer
ESCRT-II MO
morpholino + GFP
control MO
DAPI DAPI
morpholino + GFP
(b)(a)
(c) (d)
contralateral
eye
electroporated
eye
contralateral
eye
**
n.s.
control MOESCRT-II KD
0 2 4 6 8 10 12
no. labelled axons exiting eye
0
5
10
15
20
25
30
35
(e)
n
o
. 
la
be
lle
d 
ce
lls
 in
 R
G
C 
la
ye
r
Figure 3. ESCRT-II knockdown impairs axon exit from the eye. (a,b) Images of in vivo ventral preparation of Xenopus embryos electroporated with GFP þ control
MO (a) or GFP þ ESCRT-II MO (b). Note very few axons exiting the eye and coursing to optic tectum in (b). A vertical yellow line indicates the midline. (c,d) Sections
of embryos’ eyes electroporated with GFP þ either a control MO (c; n ¼ 6) or ESCRT-II MO (d; n ¼ 7) stained with DAPI (blue) and GFP (green). (e) Quantification
of (c) and (d ). Graph shows the average number of labelled cells (vertical axis) and the corresponding number of axons in the optic path (horizontal axis) in both
conditions. **p  0.001, Student’s t-test. ONH, optic nerve head. Scale bars, 100 mm (a,b), 50 mm (c,d).
rsob.royalsocietypublishing.org
Open
Biol.6:150218
7
DCC at the plasma membrane, which is consistent with the
deficient response to Netrin-1 (figure 4).
3.6. DCC rescues ESCRT-II deficiency
The finding that both total and surface DCC decrease with
ESCRT-II depletion raised the possibility that DCC loss
underlies the ESCRT-II phenotype. If this is correct,
we reasoned that restoring DCC levels should rescue the
ESCRT-II phenotype. To address this, we electroporated a
DCC-expression plasmid together with ESCRT-II MO and
a gap-GFP reporter into stage 26 Xenopus eyes and counted
the number of fluorescent axons exiting the eyes and navigat-
ing along the pathway to the optic tectum at stage 41
(figure 8a–d). ESCRT-II morphants (figure 8b) had signifi-
cantly fewer axons in the optic pathway than control
embryos (2.50+0.4 axons versus 9.25+0.73; figure 8a,d).
Co-electroporation of ESCRT-II MO with the DCC-expressing
plasmid resulted in an increase of the number of labelled
axons exiting the eye (4.40+0.58; figure 8c,d), indicating that
DCC overexpression is sufficient to at least partially rescue
the in vivo phenotypes in ESCRT-II knockdown.
We therefore hypothesized that DCC expression could
restore sensitivity to Netrin-1 in ESCRT-II-depleted GCs. To
test this, we performed a turning assay, where growing axons
in vitro are exposed to a gradient of guidance cue [56,57]. In
agreement with previous studies [53], control MO-injected
RGC axons showed a strong attractive turning response to a
Netrin-1 gradient (mean turning angle þ 13.78+6.498,
figure 8e,h,k,n).As expected, ESCRT-II-depleted axons exhibited
no directional response to a Netrin-1 gradient (mean turning
angle of 25.59+5.768, figure 8f,i,l,n). However, re-expression
of DCC in ESCRT-II-depleted axons restored their responsive-
ness to Netrin-1 (mean turning angle of þ 15.77+5.568,
figure 8g,j,m,n). This suggests that the regulation of DCC
by ESCRT-II is needed for the Netrin-1 gradient-sensing
turning mechanism.
3.7. ESCRT-II knockdown reduces local protein synthesis
DCC activation by Netrin-1 triggers LPS in GCs [58], and
the local translation of b-actin mRNA has been shown to
mediate GC turning in vitro [10,11]. Given that ESCRT-II
has been identified as an RNA-binding protein [28], we
asked if ESCRT-II depletion affects PS in the GC. We
assayed the de novo PS using the AHA incorporation
assay [59]. ESCRT-II knockdown resulted in significantly
reduced baseline levels of PS in GCs (67+ 7% of control,
figure 9a–c). The 1-h period of incubation required for
AHA labelling meant that this method could not be used
to assess the rapid Netrin-1-induced PS [58]. Instead, we
took advantage of the aminonucleoside antibiotic
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puromycin, which at low concentrations can be used to label
nascent proteins without blocking translation [60–63], and
we quantified the signal using a fluorescent anti-puromycin
antibody [63]. In line with previous studies [58], Netrin-1
stimulation caused a significant increase in puromycin
signal in control GCs, indicative of increased LPS
(figure 9d,e,h). By contrast, in ESCRT-II-depleted GCs, puro-
mycin staining did not show any increase with Netrin-1
stimulation (figure 9f–h). Consistent with the AHA labelling
experiment, ESCRT-II morphants exhibited a much lower
level of basal PS (0 min; figure 9h). These results show
that ESCRT-II abolishes Netrin-1-stimulated PS in GCs con-
sistent with a loss of DCC signalling. In addition, ESCRT-II
KD substantially lowers basal (unstimulated) levels of
de novo PS in GCs.
Because the basal level of translation is decreased in
ESCRT-II KD GCs and ESCRT-II is reportedly an RNA-
binding protein [28], we asked whether ESCRT-II transports
mRNA. b-actin mRNA is abundant in RGC GCs [64], and
is locally translated in response to Netrin-1 in RGC GCs
[10]. ESCRT-II–GFP plasmid and fluorescently labelled
b-actin mRNA were electroporated into retinal neurons, and
time-lapse imaging was subsequently performed on axons
in retinal explant cultures (figure 9i). We observed dynamic
granules of ESCRT-II–GFP trafficking along axons in both
anterograde and retrograde directions and these were com-
monly positive for b-actin mRNA (figure 9j– l and
electronic supplementary material, movie S1). These results
show that ESCRT-II and mRNAs co-localize and travel
together in the same RNA granules and suggest that
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ESCRT-II may play an active role in RNA trafficking along
axons in neurons.
4. Discussion
Todate, only a few studies have investigatedESCRTmachinery
in developing axons and these have focused primarily on
ESCRT-0 and ESCRT-III [34,35]. Here, we have characterized
for the first time, to the best of our knowledge, the localization
of ESCRT-II in Xenopus RGC GCs and have investigated the
effect of ESCRT-II depletion on retinal axon growth in vitro
and in vivo. Briefly, our results show that (i) ESCRT-II associ-
ates with the endosomal pathway in GCs; (ii) ESCRT-II KD
impairs axon exit from the eye in vivo and abolishes Netrin-1-
guided responses in vitro; (iii) ESCRT-II depletion causes a
loss of DCC in GCs and DCC expression rescues defects in
axon growth; (iv) ESCRT-II depletion lowers the basal rate of
PS in the GC and abolishes Netrin-1-induced PS increase;
and (v) ESCRT-II co-transports with mRNA in axons.
The ESCRT system is classically known to sort and package
ubiquitylated cargo into the intraluminal vesicles inside late
endosomes, thus forming multivesicular bodies (MVBs) [21].
Our results show that that ESCRT-II also co-localizes with
early and recycling endosomes. We find that ESCRT-II KD
causes a decrease in FM4-64 dye loading, indicating that
ESCRT-II could have an early function in the dynamic
regulation of the endocytosis and/or recycling and re-insertion
of the endosomes into the plasma membrane of RGC GCs.
Indeed, recent studies link ESCRT machinery to the early/
recycling part of the endosomal system. For example, Hrs
(ESCRT-0) was found to associate with a subset of clathrin
pits at the plasma membrane, where it sorts surface cargo
even before endocytosis to facilitate downstream trafficking
[65]. On the other hand, one of ESCRT-III’s subunits, Ist1, was
shown to interact with spastin in early endosomes, controlling
the fission of recycling endosomes and the sorting of recycling
cargoes away fromthedegradationpathway [34]. These studies,
together with our results, indicate that ESCRT-II could poten-
tially interact with other components of the ESCRT machinery
to control the dynamics of endosomal recycling.
Although the canonical view holds that the multiprotein
ESCRT system acts as a whole to control cargo sorting, mem-
brane bending and fission [21], emerging evidence suggests
that individual elements of the ESCRT system can act indepen-
dently of each other. For example, the ESCRT-II subunit Vps25
acts independently of Hrs to decrease Notch signalling in Dro-
sophila imaginal discs [66], and the ESCRT-III element Vps32
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regulates exovesicle secretion via a mechanism that is distinct
from MVB formation [67]. ESCRT-II has been shown to work
independently of ESCRT-I and III in regulating degradation
but not in the recycling of EGFR [68]. Interestingly,
the reported role of ESCRT-II as an RNA binding protein in
Drosophila oocytes [28] also did not require other ESCRTs.
It is possible, therefore, that in Xenopus RGC growth cones,
ESCRT-II also acts in a non-canonical way. Thus, even
though previous studies showed that some ESCRT com-
ponents, such as ESCRT-0 [65], are dispensable for
endocytosis, we cannot exclude an independent role of
ESCRT-II in the regulation of endocytosis in RGC growth
cones. In particular, ESCRTs have previously been suggested
to control surface levels of various receptors, indicating their
possible involvement in endo- and/or exocytosis. For example,
overexpression of the ESCRT-III component CHMP6 leads to
increased removal of the transferrin receptor from the plasma
membrane [69], whereas disruption of Vps25 function causes
increased surface presence of active Notch [66,70]. Taken
together, this indicates that ESCRT-II might act in a non-
canonical as well as canonical way, to regulate the dynamics
between endocytosis and recycling/exocytosis.
Our results indicate that ESCRT-II associates with endo-
somal vesicles that can contribute to membrane removal.
The balance between endocytosis and exocytosis in growth
cones is a key regulator of axon growth: excess exocytosis
permits extension, whereas excess endocytosis enables retrac-
tion [46–50]. Our finding that ESCRT-II KD leads to
accelerated growth of RGC axons in vitro could arise from a
shift in the balance of endocytosis/exocytosis with the inser-
tion of new membrane by exocytosis exceeding membrane
removal by endocytosis, thereby fuelling increased extension.
Interestingly, it appears that GC morphology and advance
critically depend on the correct localization of endosomes.
For example, recent evidence shows that specifically directing
Rab11 endosomes into or out of the GC leads to axon growth
enhancement or suppression, respectively [71]. In future
studies, it will be of interest to assess the exact role of ESCRT-
II in endosomal trafficking andmembrane flow. The accelerated
growth is unlikely to be due to the loss of DCC receptor in
ESCRT-II morphants, because DCC activation increases axon
growth [72].
The finding that DCC rescues the axon guidance defects
in ESCRT-II-depleted axons both in vivo and in vitro indicates
that the loss of DCC receptor, primarily, underlies the axon
guidance phenotypes. ESCRT-II morphants exhibited
reduced retinal projections with fewer axons exiting the eye
and crossing the diencephalon. This defect is similar to
Netrin-1 hypomorphs and DCC knockout mice [51] and
probably arises owing to a failure of axons to turn into the
optic nerve head, a key choice point known to require
Netrin-1–DCC signalling [51,53]. In addition, ESCRT-II-
depleted axons, like DCC-compromised axons [53], are not
able to turn in a Netrin-1 gradient.
Although DCC fully rescued the turning defect in vitro,
the rescue was only partial in vivo, so alternative and/or
additional hypotheses should be considered. For instance,
the reduced number of axons exiting the ESCRT-II morphant
eyes could be due, at least partially, to disrupted axogenesis.
The robust growth of ESCRT-II-depleted axons observed
in vitro, however, argues against this possibility. Another
hypothesis is that ESCRT-II KD affects other guidance mech-
anisms that ultimately cause RGC axons to miss the entrance
to the optic nerve head. For example, mice lacking Slit-1 and
Slit-2 also exhibit axon misrouting at the optic nerve head
[73], and the Slit-2 response is dependent on both endocytosis
and new PS [74]. Additionally, other guidance systems for
axon growth involving EphB and L1 within the retina
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[75,76] are regulated by endocytosis [7,77,78] and show simi-
larities when knocked down to the ESCRT-II knockdown
phenotype [75,76], suggesting that ESCRT-II might also regu-
late these pathways.
Our results show that ESCRT-II regulates the levels of DCC
receptor in the GC, although the mechanism for this is not
clear. The high degree of co-localization of ESCRT-II and
DCC in GCs, confirmed by the PLA assay, suggests that they
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of the area marked with orange broken arrow in the merge images (k), showing the movement of one ESCRT-II andb-actin mRNA-positive granule (bottom to top of the three
kymographs in l ), while another one remains stationary (at the top of each kymograph in l ).
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may interact directly. One possibility is that ESCRT-II binds
DCC in the soma and transports it along the axon to the GC.
Our finding that the levels of both surface and internal DCC
in the growth cone decrease by the same amount with
ESCRT-II knockdown is consistent with a global mechanism
of this sort, rather than a local one. Another possibility is that
the loss of axonal PS caused by ESCRT-II KD eliminates the
local de novo supply of DCC. The reappearance of DCC on
the GC surface after its removal through Netrin-1-induced
endocytosis is sensitive to PS inhibition [5]. However, there is
no direct evidence that DCC itself is axonally synthesized.
DCC is rapidly endocytosed after Netrin-1-stimulation [5,79]
and subsequently degraded [79]. Thus, an alternative possi-
bility is that by associating with early/recycling endosomes,
ESCRT-II could protect DCC from Netrin-1-induced degra-
dation, although the unchanged surface/total ratio of DCC in
ESCRT-II KD argues against this. It is notable that ESCRT-II
morphant GCs do not respond to a Netrin-1 gradient in vitro
despite losing only about 50% of their DCC. This suggests
that ESCRT-II functionmay be involved in the gradient sensing
mechanism, where the stoichiometric proportions of DCC to
otherNetrin-1 receptors (e.g. neogenin orUNC-5) could be cru-
cial for correctly responding directionally to guidance cues. On
the other hand, the Netrin-1-induced endocytosis of the
remaining 50% of DCC left in ESCRT-II morphant GCs could
contribute to the decrease of axon speed in vitro.
Our live imaging experiments provide direct evidence that
ESCRT-II–GFPassociateswith b-actinmRNA inmoving gran-
ules in retinal axons. This observation indicates that ESCRT-II
may bind and transport mRNA in axons and suggests that it
may play amajor role in RNA localization in axons. This is con-
sistent with results in Drosophila showing that ESCRT-II binds
and localizes bicoid mRNA in the oocyte [28]. The mobile
ESCRT-II-mRNA-labelled granules in axons are reminiscent
of the endosome–mRNA granules seen in fungal hyphae
[30]. These long cellular structures, somewhat analogous to
axons, are known to transport mRNA on endosomes to distant
subcellular locations where de novo PS takes place locally [12].
If ESCRT-II plays amajor role inmRNA transport in axons, this
could provide an explanation for the significant reduction in
basal levels of axonal PS following ESCRT-II KD. If fewer
mRNAs reach the axon, then it follows that there will be a
drop in LPS. In future studies, it will be interesting to investi-
gate whether ESCRT-II-depleted axons harbour fewer
mRNAs.
In summary, our findings indicate that ESCRT-II is
involved in controlling RGC axonal guidance through DCC
signalling. Furthermore, the simultaneous loss of endocytosis
and basal LPS suggests that ESCRT-II plays a novel role in
the coordinate regulation of these two processes. Our studies
raise new questions about how ESCRT-II functions in axonal
GCs, and particularly whether its role in the early steps of
endocytosis and endosomal sorting to the recycling pathway
is the primary mechanism underlying these functions.
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